Glasses pen newspaper

Carl Zeiss Meditec Share

Investing in Carl Zeiss Meditec, is an investment in the future of health. We drive the development of leading-edge technology and make it available for applications in the field of: ophthalmology, neurosurgery, ENT surgery, dental applications and systems for intraoperative radiotherapy in the treatment of breast cancer.

Quotes, Charts & Orderbook

Security Identification Numbers of CZM Shares  
Stock exchange abbrevation AFX
ISIN DE0005313704
Reuters Identification Code (RIC) AFXG.F (exchange floor)
  AFXG.DE (XETRA)
Bloomberg AFX GR

Key Facts at a Glance

  • Basic Data
    ISIN DE0005313704
    Trading segment Prime Standard
    Designated Sponsors Cheuvreux
    Share capital EUR 81,309,610.00
    Admitted capital EUR 81,309,610.00
    Category and nominal value No-par value bearer shares at a nominal value of EUR 1.00 per share
    Stock Markets Deutsche Börse, Frankfurt (XETRA and exchange floor, "Parkett")
    Regional stock exchanges in Berlin, Bremen, Düsseldorf, Hamburg, Munich and Stuttgart
    Capital measures 26-Oct-2006:
    Increase of the share capital of EUR 32,523,844.00 (divided into 32,523,844 no-par value shares) by EUR 48,785,766.00 to EUR 81,309,610.00 (divided into 81,309,610 no-par value shares); capital increase with subscription rights and against contributions in kind and cash contributions.

    10-May-2005:
    Increase of the share capital of EUR 29,682,182.00 against cash contribution by EUR 2,841,662.00 (approx. 10%) to EUR 32,523,844.00; subscription rights of shareholders were excluded.

    01-Feb-2005:
    Increase of the share capital of EUR 28,416,628.00 against contribution in kind by EUR 1,265,553.00 (4.45%) to EUR 29,682,182.00; subscription rights of shareholders were excluded; capital increase was part of the acquisition of the majority holding in IOLTech S.A.

    18-Sep-2003:
    Increase of the share capital of EUR 28,833,300.00 against cash contribution by EUR 2,583,329.00 (10%) to EUR 28,416,629.00; subscription rights of shareholders were excluded.
  • Dividend
      Cash Dividend
    (€ per share)
    Payout total amount
    (Mill. €)
    Day of dividend payment
    2011/2012 0.40 32.523 06-Mar-2013
    2010/2011 0.30 24.392 12-Mar-2012
    2009/2010* 0.22
    +0.33
    17.888
    44.720
    13-Apr-2011
    2008/2009 0.18 14.635 05-Mar-2010
    2007/2008 0.18 14.635 20-May-2009

    * regular Dividend 0.22€ + one off special dividend 0.33€

  • Key Share Data
      2011/12
    2010/11 2009/10 2008/09 2007/08 2006/07
    XETRA
    Year-end price (EUR)* 19.92
    13.36 11.55 11.11   10.14 15.43
    Year high (EUR)* 21.40
    16.44 13.06 11.41 16.00 18.44
    Year low (EUR)* 13.00
    11.57 9.78 7.33 7.40 13.13
    Year average (EUR) 17.41
    14.28 11.55 9.46 10.47 15.74
    Daily order book turnover (XETRA) in fiscal year
    EUR 1,128,168
    992,460 492,030 843,908 1,211,527 1,534,413.9
    Shares 64,800
    69,500 42,600 89,208 115,750 97,485
    Number of shares as of 30. September (million shares) 81.310
    81.310 81.310 81.310 81.310 81.310
    Market capitalization as of 30. September (thousand EUR) 1,619,687
    1,086,296 939,126 903,349 824,479 1,254,607
    Earnings per share (EUR) 0.88
    0.82 0.68 0.62 0.66 0.61
    Dividend per share (EUR) 0.40
    0.30 0.22+0.33 0.20 0.18 0.16+0.27
    Dividend yield (%)* 3.00
    2.68 4.76 1.80 1.78 2.78

    * End of fiscal year: 30. September

  • Research Coverage
    Bank/Analyst Phone Current Rating Previous
    HSBC
    Jan Keppeler
    +49-211-9 10 24 46 Underweight (08-04-2013) Underweight
    Berenberg Bank
    Scott Bardo
    +44-(0)-20-3207 7869
    Buy (15-02-2013)
    Buy
    Kepler Capital Markets
    Maja Pataki
    +41-43 333 66 23 Reduce (15-02-2013) Buy
    Nord/LB
    Holger Fechner
    +49-511-3 61 53 05 Hold (14-02-2013) Buy
    Cheuvreux
    Oliver Reinberg
    +49-69-47 89 75 26 Underperform (14-02-2013) Underperform
    Deutsche Bank
    Gunnar Romer
    +49-69-91 03 19 17 Hold (14-02-2013) Hold
    DZ Bank
    Sven Kürten
    +49-69-7 44 79 20 72 Sell (14-02-2013) Sell
    LBBW
    Volker Stoll
    +49-711-127 70568 Hold (14-02-2013) Hold
    Commerzbank
    Volker Braun
    +49-69-13 64 76 59 Hold (14-02-2013) Buy
    J.P. Morgan Cazenove
    David Adlington
    +44-(0)-20-71 34 58 28
    Overweight (14-02-2013)
    Overweight
    Jefferies
    Ingeborg Oie
    +44-(0)-20 7898 74 23 Hold (13-09-2012) Hold

    Please note: Banks and securities firms use different terms for their equity ratings.The information contained in the table is based on publicly available sources that we consider reliable but for which we do not assume any liability.

    In particular, we do not guarantee that the information is complete, accurate or up-to-date. All ratings are based on opinions given by the analysts in question. These do not necessarily reflect the opinion of Carl Zeiss Meditec AG. The assessments may change at any time without prior notice. Exemption from liability applies to Carl Zeiss Meditec AG; it does not refer to the correct rendering of the information based on external sources, in particular public sources.

    Analyst assessments relating to Carl Zeiss Meditec AG shares are only revised each quarter and are therefore not continually updated.

    Last updated: 11-04-2013

  • Shareholder Structure

    The Carl Zeiss Group holds up to 65 % - see the Chart to get an overview.

Link correlati

For more information: Quotes, Charts & Orderbook

Su questo sito Web utilizziamo cookie. I cookie sono piccoli file di testo che vengono memorizzati dai siti Web sul computer dell’utente. Ampiamente utilizzati, i cookie sono strumenti di ausilio per migliorare le pagine e rappresentarle in maniera ottimizzata. Consultando le nostre pagine l’utente acconsente al loro impiego. Di più
Di più OK